Children's Hospital of Western Ontario

London, Ontario N6C 2V5

0 studies enrolling now · 43 studies all time

What they study most

Angelman Syndrome, Becker Muscular Dystrophy, Brain Tumor, Brain Tumors, Brain and Central Nervous System Tumors, Central Nervous System Tumor, Central Nervous System Tumors, Crohn Disease, Duchenne Muscular Dystrophy, Fever, Sweats, and Hot Flashes, Functional Constipation in Children Ages 6-17 Years, Genetic Diseases, Inborn

Studies at this site

• A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome — Completed
• A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease — Completed
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor — Completed
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma — Completed
• Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer — Completed
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation — Stopped early
• An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy — Stopped early
• Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) — Completed
• Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) — Stopped early
• High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma — Completed
• Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma — Completed
• Radiation Therapy in Treating Young Patients With Gliomas — Completed
• Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma — Completed
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) — Completed
• Surgery in Treating Children With Neuroblastoma — Completed
• DNA Variations in the Gene in Young Patients With Wilms' Tumor — Completed
• Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia — Completed
• Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children — Completed
• Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate — Completed
• hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma — Completed
• Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma — Completed
• Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma — Completed
• Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia — Completed
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma — Completed
• Combination Chemotherapy in Treating Children With Neuroblastoma — Completed
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers — Completed
• Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia — Completed
• Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors — Completed
• Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma — Completed
• STI571 in Treating Patients With Recurrent Leukemia — Completed
• Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia — Completed
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma — Completed
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma — Completed
• Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy — Completed
• Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma — Completed
• Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma — Stopped early
• Combination Chemotherapy in Treating Children With Progressive Brain Tumors — Completed
• Lobradimil and Carboplatin in Treating Children With Brain Tumors — Completed
• Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome — Completed
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma — Completed
• Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas — Completed
• Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma — Completed